T3 Pharmaceuticals
SwitzerlandEntry
2019
Hold
4yr
Exit
2023
Who owns T3 Pharmaceuticals?
T3 Pharmaceuticals was owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage) from 2019 to 2023, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-07
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
Germany
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track T3 Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy T3 Pharmaceuticals?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on T3 Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue